TME Pharma N.V. (EPA:ALTME)
France · Delayed Price · Currency is EUR 0.0892
+0.0014 (1.59%)
Aug 21, 2026, 5:35 PM CET
TME Pharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -3.29 | -5.72 | -6.74 | -15.13 | -14.45 |
Depreciation & Amortization | 0.02 | 0.08 | 0.14 | 0.09 | 0.07 |
Other Amortization | 0.03 | 0.02 | - | 0.12 | 0.05 |
Stock-Based Compensation | 0.09 | 0.31 | 0.4 | 0.59 | 0.48 |
Other Operating Activities | 0.39 | 0.46 | 1.12 | 2.91 | 1.08 |
Change in Accounts Payable | -0.67 | 0.19 | -0.79 | -0.58 | 0.42 |
Change in Other Net Operating Assets | 0.01 | 0.02 | 0.24 | -0.14 | -0.01 |
Operating Cash Flow | -3.42 | -4.63 | -5.64 | -12.14 | -12.38 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | -0.02 | -0.02 | -0.02 | -0.01 |
Sale of Property, Plant & Equipment | 0.01 | - | - | - | - |
Investment in Securities | - | -0.01 | - | - | - |
Other Investing Activities | 0.01 | - | - | - | - |
Investing Cash Flow | 0.01 | -0.02 | -0.02 | -0.02 | -0.01 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | 2.21 | - | - | - | - |
Long-Term Debt Issued | - | - | 1 | 7.43 | 4.37 |
Total Debt Issued | 2.21 | - | 1 | 7.43 | 4.37 |
Long-Term Debt Repaid | - | -1.22 | -1.04 | -0.06 | -0.03 |
Net Debt Issued (Repaid) | 2.21 | -1.22 | -0.04 | 7.37 | 4.35 |
Issuance of Common Stock | 0.01 | 7.28 | 3.17 | 0.09 | 7.22 |
Repurchase of Common Stock | - | -0 | -0 | -0.03 | -0 |
Other Financing Activities | -0.03 | -0.4 | 0.14 | -0.15 | -0.07 |
Financing Cash Flow | 2.18 | 5.66 | 3.27 | 7.29 | 11.5 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | -0.01 | -0 | 0.06 | 0.05 |
Net Cash Flow | -1.23 | 1 | -2.39 | -4.82 | -0.85 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.42 | -4.65 | -5.65 | -12.16 | -12.4 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | - | - | - | - | -37560.61% |
Free Cash Flow Per Share | -0.04 | -0.13 | -1.13 | -10.34 | -18.79 |
Levered Free Cash Flow | -2.12 | -2.71 | -3.58 | -7.35 | -7.36 |
Unlevered Free Cash Flow | -2.13 | -2.72 | -3.57 | -7.39 | -7.38 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | 0 | 0.01 | 0.01 | 0 |
Cash Income Tax Paid | - | - | 0.01 | - | - |
Change in Working Capital | -0.66 | 0.22 | -0.56 | -0.72 | 0.41 |